Monitoring democratic institutions through public records
Independent Agency Rules — Week of Jul 13, 2026
Some government agencies (like the FDA or EPA) are supposed to make decisions based on science and law, not politics. Can the President control what rules they write?
AI content assessment elevated
AI two-pass review flags anomalous content with P2 corroboration. Monitoring increased.
This week, President Trump issued a proclamation exempting specific chemical manufacturing facilities from air pollution rules that the EPA finalized in 2024 under the Clean Air Act. The proclamation, titled Regulatory Relief for Certain Stationary Sources To Promote American Chemical Manufacturing Security, argues that these facilities are critical to national security and that the EPA's rules impose unworkable requirements. However, the legal provision cited — which allows waivers when specific facilities can't meet standards due to technology limitations — appears to have been designed for individual cases, not sweeping presidential exemptions covering lists of named facilities.
This might matter because the EPA's authority to set air pollution standards based on scientific evidence — independent of political pressure — could be weakened if a president can override finalized rules by proclamation for specific companies. Separately, a congressional floor speech by Rep. DeSaulnier alleged that the FDA relaxed e-cigarette marketing rules shortly after a $5 million political donation from a tobacco company and a presidential dinner with tobacco executives, raising questions about whether political contributions influenced an agency's public health decisions.
There are reasonable alternative explanations. The chemical manufacturing proclamation may reflect a genuine policy disagreement about whether EPA's compliance timelines are realistic — some facilities may truly lack the technology to meet the new standards on schedule. Presidents have broad authority to prioritize national security, and chemical supply chains are legitimately important. Regarding the e-cigarette allegations, regulatory changes typically take months of internal review, so the tight timeline described by one congressman may reflect coincidence rather than causation, and the FDA may have had independent scientific reasons for its guidance.
Limitations: This is AI-generated analysis of published government documents, not a finding of fact. The legal questions raised by the chemical manufacturing proclamation will likely require court review to resolve. The e-cigarette allegation comes from a single floor speech and has not been independently investigated.